News | Atrial Fibrillation | May 15, 2018

Marijuana Use Does Not Increase Risk of Arrhythmias, Might Reduce AFib Risk

HRS late-breaking study authors say further investigation is needed to understand the temporal relationship of marijuana and arrhythmias

Marijuana Use Does Not Increase Risk of Arrhythmias, Might Reduce AFib Risk. #HRS2018

May 15, 2018 — According to new research, smoking marijuana may not be associated with an increased risk of ventricular fibrillation (VF) and ventricular tachycardia (VT) following an acute myocardial infarction (AMI). The study also reported that marijuana users had a decreased risk of atrial fibrillation (AFib) and in-hospital mortality. The results of the study were presented at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions. 

Recent federal data reported a stunning 455 percent increase in marijuana consumption among U.S. adults ages 55-64 years and 333 percent in ages over 64 years between 2002 and 2014 [1]. In fact, one in eight Americans say they smoke marijuana [2]. While results of previous studies show links between cannabis use and increases in heart rate and blood pressure, little is known about the cardiac-related effects for heart arrhythmias including VF and VT.  

The study compared clinical profiles and in-hospital outcomes between reported marijuana users vs. non-users from 1994 to 2013. The primary endpoint was VT/VF or cardiac arrest and the secondary endpoint was atrial fibrillation or mortality. The patient group included people between the ages of 18-70 years with a primary diagnosis of AMI (ICD-9-CM code 410.xx) from eight states including California, New York, New Jersey, Vermont, New Hampshire, Colorado, Texas and West Virginia. Patients who used cocaine, methamphetamine or alcohol were excluded from the study. Variables included in a step-forward multivariate logistic regression model included age, race and cardiac risk factors. 

In total, 3,854 of 1,273,897 patients admitted with AMI reported marijuana use. Findings from the study show marijuana users tended to be younger, male and less likely to have coronary artery disease (CAD) or coronary risk factors than non-users. Primary endpoints show that 9.7 percent (n=374) marijuana users and 9.7 percent (n=122,797) non-users experienced VT/VF or cardiac arrest. Secondary endpoints show that 4.5 percent (n=173) marijuana users vs. 8.7 percent (n=110,153) non-users had AFib, and 4 percent (n=135) vs. 6 percent (n=75,311) died, respectively. Despite there being no difference in the risk for VT/VF, researchers found in-hospital mortality was lower in marijuana users and a trend toward decreased risk of AFib was lower in marijuana users. 

"The legalization of marijuana is spreading quickly across the U.S. resulting in more people using it, but we still don’t know the true, long-term impact it has on one’s heart health. Our study is the first to examine the relationship between marijuana use after a heart attack and various arrhythmias and we did not see a negative connection," said senior author Christine Tompkins, M.D., assistant professor of cardiology medicine at University of Colorado School of Medicine. "We are just one step closer to a better understanding of the various heart effects of marijuana, so that we are able to take the necessary actions to provide optimal patient care." 

The authors have noted that future studies are warranted to further understand the temporal relationship of marijuana and arrhythmias in patients with chronic ischemic heart disease, and are actively involved in a prospective observational study. They have also expressed interest in understanding the effects of marijuana in other chronic cardiac conditions, such as congestive heart failure and hypertension. The authors emphasize a need to understand how marijuana affects the heart so as to provide patients with informed choices, particularly since use in adults over the age of 50 years is increasing exponentially.  

Heart Rhythm 2018 is the most comprehensive educational program for heart rhythm professionals, featuring more than 200 educational sessions and more than 140 exhibitors showcasing innovative products and services. For more information: www.hrssessions.org

Find links to all the Heart Rhythm 2018 Late-breaking Studies

 

References: 

1. Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014. MMWR Surveill Summ 2016;65 (No. SS-11):1–25. DOI: http://dx.doi.org/10.15585/mmwr.ss6511a1.

2. Gallup, Inc. "In U.S., 45% Say They Have Tried Marijuana." Gallup.com,  19 July 2017, news.gallup.com/poll/214250/say-tried-marijuana.aspx.  

 

#HRS2018 #HRS18

Related Content

PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the
Results of the Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study at HRS 2020. #HRS2020 #Heartrhythm2020,
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking
Contact Force Sensing Catheter Improved Outcomes in Persistent Atrial Fibrillation Ablation. #HRS2020 #heartrhythm2020
News | Atrial Fibrillation | May 13, 2020
May 13, 2020 — The PRECEPT study testing the use of the Biosense Webster Thermocool Smarttouch SF Catheter for the tr
The Swiss-AF study shows High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation | May 08, 2020
May 8, 2020 – A new clinical study found that patients with...
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation | May 08, 2020
May 8, 2020 — Positive 12-month results were announced today from the...
The first-in-human results show positive results for Medtronic's pulsed field ablation in safety and efficiency. #Heartrhythm2020 #HRS2020 #HRS20
News | Atrial Fibrillation | May 08, 2020
May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation
POPULAR TAVR trial Shows Oral Anticoagulants Alone in atrial fibrillation  (AF) Patients Reduces Bleeding Post TAVR, transcatheter aortic valve replacement. #ACC20 #ACC2020
News | Atrial Fibrillation | March 29, 2020
March 29, 2020 — Patients with atrial fibrillation (AF) who took oral anticoagulants alone after undergoing transcath
Medtronic's PulseSelect Pulsed Field Ablation (PFA) System

Medtronic's PulseSelect Pulsed Field Ablation (PFA) System.

News | Atrial Fibrillation | January 31, 2020
January 31, 2020 – The U.S.
Frequent Drinking Greater Risk Factor for Heart Rhythm Disorder Than Binge Drinking

Image courtesy of the American Heart Association.

News | Atrial Fibrillation | October 22, 2019
October 22, 2019 —  Drinking small amounts of alcohol frequently is linked with a higher likelihood of...